Jul 2024 Articles

Articles
ORION-8: one step closer to understanding the safety and efficacy of inclisiran
Tokgözoğlu L, Norata GD
Journal:
Cardiovasc Res

First published: July 31, 2024 DOI: 10.1093/cvr/cvae166
View
- Share
Articles
Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
Hosseini K, Soleimani H, Maleki S, et al.
Journal:
BMC Cardiovasc Disord

First published: July 30, 2024 DOI: 10.1186/s12872-024-04057-w
View
- Share
Articles
Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study
Weichsel L, André F, Renker M, et al.
Journal:
Clin Res Cardiol

First published: July 30, 2024 DOI: 10.1007/s00392-024-02502-6
View
- Share
Articles
Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial
Singh A, Laffin LJ, Sarraju A, et al.
Journal:
Clin Cardiol

First published: July 30, 2024 DOI: 10.1002/clc.24328
View
- Share
Articles
Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What’s a Clinician to Do?
Khan SS, Lloyd-Jones DM
Journal:
JAMA

First published: July 29, 2024 DOI: 10.1001/jama.2024.13887
View
- Share
Articles
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry
Shiyovich A, Berman AN, Besser SA, et al.
Journal:
Cardiovasc Diabetol

First published: July 18, 2024 DOI: 10.1186/s12933-024-02348-2
View
- Share
Articles
Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis
Arsenault BJ, Loganath K, Girard A, et al.
Journal:
JAMA Cardiol

First published: July 17, 2024 DOI: 10.1001/jamacardio.2024.1882
View
- Share
Articles
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation
Nurmohamed NS, Gaillard EL, Malkasian S, de Groot RJ, et al.
Journal:
JAMA Cardiol

First published: July 17, 2024 DOI: 10.1001/jamacardio.2024.1874
View
- Share
Articles
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs
Lincoff AM, Ray KK, Sasiela WJ, et al.
Journal:
J Am Coll Cardiol

First published: July 9, 2024 DOI: 10.1016/j.jacc.2024.04.048
View
- Share
Articles
Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries
Reijman MD, Tromp TR, Hutten BA, et al.
Journal:
Lancet Child Adolesc Health

First published: July 8, 2024 DOI: 10.1016/S2352-4642(24)00073-7
View
- Share
Articles
Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials
Wright RS, Ray KK, Landmesser U, et al.
Journal:
Mayo Clin Proc

First published: July 5, 2024 DOI: 10.1016/j.mayocp.2024.03.025
View
- Share
Articles
The LDL cumulative exposure hypothesis: evidence and practical applications
Ference BA, Braunwald E, Catapano AL
Journal:
Nat Rev Cardiol

First published: July 5, 2024 DOI: 10.1038/s41569-024-01039-5
View
- Share

1 2

Jul 2024 Articles

Articles

ORION-8: one step closer to understanding the safety and efficacy of inclisiran

Tokgözoğlu L, Norata GD

Articles

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis

Hosseini K, Soleimani H, Maleki S, et al.

Articles

Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study

Weichsel L, André F, Renker M, et al.

Articles

Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial

Singh A, Laffin LJ, Sarraju A, et al.

Articles

Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What’s a Clinician to Do?

Khan SS, Lloyd-Jones DM

Articles

Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry

Shiyovich A, Berman AN, Besser SA, et al.

Articles

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis

Arsenault BJ, Loganath K, Girard A, et al.

Articles

Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation

Nurmohamed NS, Gaillard EL, Malkasian S, de Groot RJ, et al.

Articles

Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs

Lincoff AM, Ray KK, Sasiela WJ, et al.

Articles

Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

Reijman MD, Tromp TR, Hutten BA, et al.

Articles

Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials

Wright RS, Ray KK, Landmesser U, et al.

Articles

The LDL cumulative exposure hypothesis: evidence and practical applications

Ference BA, Braunwald E, Catapano AL

Articles

ORION-8: one step closer to understanding the safety and efficacy of inclisiran

Tokgözoğlu L, Norata GD

Share

Articles

Early administration of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis

Hosseini K, Soleimani H, Maleki S, et al.

Share

Articles

Effects of high- versus low-intensity lipid-lowering treatment in patients undergoing serial coronary computed tomography angiography: results of the multi-center LOCATE study

Weichsel L, André F, Renker M, et al.

Share

Articles

Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial

Singh A, Laffin LJ, Sarraju A, et al.

Share

Articles

Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What’s a Clinician to Do?

Khan SS, Lloyd-Jones DM

Share

Articles

Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry

Shiyovich A, Berman AN, Besser SA, et al.

Share

Articles

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis

Arsenault BJ, Loganath K, Girard A, et al.

Share

Articles

Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation

Nurmohamed NS, Gaillard EL, Malkasian S, de Groot RJ, et al.

Share

Articles

Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs

Lincoff AM, Ray KK, Sasiela WJ, et al.

Share

Articles

Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

Reijman MD, Tromp TR, Hutten BA, et al.

Share

Articles

Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials

Wright RS, Ray KK, Landmesser U, et al.

Share

Articles

The LDL cumulative exposure hypothesis: evidence and practical applications

Ference BA, Braunwald E, Catapano AL

Share